Home » Topics » BioWorld Science

BioWorld Science
RSS

Merck & Co. patents lysine-specific demethylase 5B inhibitors

May 9, 2018

New RIP-1 inhibitors discovered at Roche, Genentech

May 9, 2018

Intravenous formulation of Akynzeo launched in the U.S.

May 9, 2018

Cellcentric divulges new KAT3 and/or CREB-binding protein inhibitors

May 9, 2018

Nektar Therapeutics initiates phase Ib trial of NKTR-358 in patients with SLE

May 9, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Novel serine palmitoyltransferase inhibitors identified at Takeda

May 9, 2018

Durable antidepressive effect seen with ALKS-5461 in phase III trial

May 9, 2018

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...